Arrowhead Pharmaceuticals Corp (ARWR) Reports In-Line Q3 EPS, Revenues Beat

Go back to Arrowhead Pharmaceuticals Corp (ARWR) Reports In-Line Q3 EPS, Revenues Beat
ARROWHEAD RESEARCH (NASDAQ: ARWR) Delayed: 82.00 --0 (-0%)
Previous Close $82.00    52 Week High $8.22 
Open $82.00    52 Week Low $3.07 
Day High $82.00    P/E N/A 
Day Low $82.00    EPS $-1.30 
Volume 291